Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Five Aces Breeding is a specialized agricultural biotechnology company founded in 1995 by Dr. Harry Jan Swartz, a professor at the University of Maryland. The company focuses on the advanced breeding and genetic optimization of small fruits, including raspberries, blackberries, and strawberries, to enhance flavor, yield, and nutritional content. A key aspect of its operations involves the development of unique plant genotypes for medical research, such as raspberries with specific phytochemical deletions used in clinical studies for cancer prevention. Additionally, the company has collaborated with NASA contractors to develop fruit-growing systems for long-duration space missions. Five Aces Breeding operates primarily through the licensing of its proprietary cultivars to commercial growers and research institutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Five Aces Breeding.